Recently published studies of donor CMV seropositivity's impact on mortality
. | . | . | Percent of patients with T-cell depletion . | Percent of transplants from unrelated donors . | Effect on mortality . | . | |
|---|---|---|---|---|---|---|---|
| Author . | N . | Setting . | . | . | Positive recipient . | Negative recipient . | |
| Kollman et al3 | 6878 | Mixed | 25 | 100 | None | None | |
| Nichols et al4 | 1001* | Mixed | 0 | 100 | None | Increased | |
| Ljungman et al2 | 1108 | Mixed | 27 | 100 | Decreased | NA | |
. | . | . | Percent of patients with T-cell depletion . | Percent of transplants from unrelated donors . | Effect on mortality . | . | |
|---|---|---|---|---|---|---|---|
| Author . | N . | Setting . | . | . | Positive recipient . | Negative recipient . | |
| Kollman et al3 | 6878 | Mixed | 25 | 100 | None | None | |
| Nichols et al4 | 1001* | Mixed | 0 | 100 | None | Increased | |
| Ljungman et al2 | 1108 | Mixed | 27 | 100 | Decreased | NA | |
Data restricted to unrelated donor transplants.
NA indicates not analyzed.
Also included recipients of HLA-mismatched transplants from related donors (see Table 2).